Myriamed

Myriamed is listed as a small business research supplier in the Scientist.com network, with 2 sites in 1 country.

Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Sites 2

Countries 1

Type of company: Small business

Cell Culture and Characterization

3D Cell Culture Use a scaffold-based or scaffold-free format to grow three dimensional cell and tissue structures.
Gene-Edited iPSCs Disease Models Use gene-edited iPSCs to model human diseases.
Induced Pluripotent Stem (iPS) Cell Reprogramming Generate induced pluripotent stem cells from adult somatic cells.
Isogenic Knockout iPSC Lines Mimic loss of function of genes associated with various diseases and disorders.
Stem Cell Differentiation Acquire specialized cells from differentiated stem cells.

Disease Models

Cardiovascular Metabolics Models Measure therapeutic endpoints in animal models of cardiovascular disorders.
Cardiovascular Models Test the therapeutic efficacy of drug candidates in cardiovacular disease models.
Ventricular Tachycardia Models Measure therapeutic endpoints in animal models of ventricular tachycardia.

Human Biological Samples

Human iPSC's For requesting human sourced induced pluripotent stem cells.
Human Organs-On-Chips Use Organs-On-Chips for target identification and validation, target-based screening, and phenotypic screening.

In Vitro Assays

HTS Assay Development Develop assays to use in high throughput screening.
In Vitro Efficacy Test Use in vitro models to test the efficacy of your products.

Show all 26 services 14 more

In Vitro Pharmacology

High Throughput Screening Conduct millions of chemical, genetic or pharmacological tests in a short period of time.
In Vitro Cardiovascular Models Measure stimulation and inhibition of lipolysis, adipogenesis and endothelial cell migration.
In Vitro Disease Models Screen pre-clinical candidates without the use of live animals.
In Vitro Neural Models Use cultured neurons, neuronal progenitor cells and stem cell differentiation to create cellular models of neurological disease.
Target Identification Identify the target(s) of a biologically active substance.
Target Validation Demonstrate that modification of target activity has potential therapeutic benefits.

In Vitro Toxicology

Cardiac Channels Measure the arrhythmia producing potential of test compounds.
Cardiomyocyte Toxicity Assess cytotoxic effects of pre-clinical compounds on cardiomyocytes.
Cardiotoxicity Evaluate the effect of a compound on heart electrophysiology and muscle function.
Cardiovascular Toxicology Measure the toxic effects of pre-clinical compounds.

In Vivo Pharmacokinetics

Cardiac Safety Assessment Assess cardiotoxicity using microelectrode assay technology.

Model Development

Custom Model Development Develop a custom disease model.

Safety Pharmacology

Safety Pharmacology Assess the impact of a therapeutic for human use on vital organ systems before first-in-man drug testing.
Target Safety Assessment Understand the role of your drug target and assess risks in normal physiology.

Germany Göttingen 2 sites

Separating the pharmacological wheat from the chaff to enhance safety and efficacy of new molecular entities (NMEs) is the primary goal of myriamed.. Our unique strengths are high quality secondary screens based on proprietary tissue engineered organ platforms. We offer our support to the pharmaceutical and biotech industry at an early stage of drug development to improve the attrition rate and enhance cost-effectiveness of drug development.

Website: www.myriamed.com

Work with Myriamed on Scientist.com

For prices, more details, or to contact Myriamed, visit Scientist.com.

View on Scientist.com